Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Christine L. Bui"'
Autor:
Rachel P. Ogilvie, J. Bradley Layton, Patricia C. Lloyd, Yixin Jiao, Djeneba Audrey Djibo, Hui Lee Wong, Joann F. Gruber, Ron Parambi, Jie Deng, Michael Miller, Jennifer Song, Lisa B. Weatherby, Lauren Peetluk, An-Chi Lo, Kathryn Matuska, Michael Wernecke, Christine L. Bui, Tainya C. Clarke, Sylvia Cho, Elizabeth J. Bell, Grace Yang, Kandace L. Amend, Richard A. Forshee, Steven A. Anderson, Cheryl N. McMahill-Walraven, Yoganand Chillarige, Mary S. Anthony, John D. Seeger, Azadeh Shoaibi
Publikováno v:
BMC Pediatrics, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background COVID-19 vaccines are authorized for use in children in the United States; real-world assessment of vaccine effectiveness in children is needed. This study’s objective was to estimate the effectiveness of receiving a complete pr
Externí odkaz:
https://doaj.org/article/a71040a255aa47ef99a2668dec27e3e6
Autor:
Michelle D. Hackshaw, Christine L. Bui, Amy Ladner, Nora Tu, Zahidul Islam, Mary E. Ritchey, Maribel Salas
Publikováno v:
Cancer Treatment and Research Communications, Vol 24, Iss , Pp 100189- (2020)
Background: Therapies targeting human epidermal growth factor receptor 2 (HER2) have become a focus for improving treatment outcomes in patients with gastric cancer. This literature review sought to assesses clinical outcomes, including safety, survi
Externí odkaz:
https://doaj.org/article/a3b2400ee15c4a78adced45ab276c386
Autor:
Andrea V Margulis, Marie Linder, Alejandro Arana, Anton Pottegård, Ina Anveden Berglind, Christine L Bui, Nina Sahlertz Kristiansen, Shahram Bahmanyar, Lisa J McQuay, Willem Jan Atsma, Kwame Appenteng, Milbhor D'Silva, Susana Perez-Gutthann, Jesper Hallas
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0204456 (2018)
PURPOSE:To describe the use of antimuscarinic drugs to treat overactive bladder (OAB) in Denmark, Sweden, and the United Kingdom (UK). METHODS:We identified new users of darifenacin, fesoterodine, oxybutynin, solifenacin, tolterodine, and trospium ag
Externí odkaz:
https://doaj.org/article/5c7ff1827f6b40b49627f2619eafb006
Autor:
Andrea V. Margulis, Kwame Appenteng, Stefan de Vogel, Susana Perez-Gutthann, Lisa J. McQuay, Alejandro Arana, Cristina Varas-Lorenzo, Billy Franks, Maria Reynolds, Alicia Gilsenan, Christine L. Bui, Cristina Rebordosa
Publikováno v:
Pharmacoepidemiology and Drug Safety
Purpose Strategies to identify and validate acute myocardial infarction (AMI) and stroke in primary‐care electronic records may impact effect measures, but to an unknown extent. Additionally, the validity of cardiovascular risk factors that could a
Autor:
Alejandro Arana, Jennifer L. Bartsch, Joan Fortuny, Andrea V. Margulis, Susana Perez-Gutthann, Lisa J. McQuay, Estel Plana, Christine L. Bui, James A. Kaye
Publikováno v:
Pharmacotherapy
tudy Objective To estimate the incidence of 10 common cancers among patients treated with antimuscarinic medications for overactive bladder (AMOAB). Design Retrospective cohort study. Data Source United Kingdom's Clinical Practice Research Datalink.
Autor:
Brian Calingaert, Francisca González-Rubio, Alejandro Arana, Marie Linder, Jordi Castellsague, Cristina Varas-Lorenzo, Beatriz Poblador-Plou, Alexandra Prados-Torres, Tilo Blenk, Oliver Scholle, Susana Perez-Gutthann, Anna Citarella, Albert Roso-Llorach, Christine L. Bui, Maria Giner-Soriano, Edeltraut Garbe
Publikováno v:
Pharmacoepidemiology and Drug Safety. 26:615-624
Purpose To describe the characteristics of new users of cilostazol in Europe with the aim to support the evaluation of its benefit/risk as used in regular clinical practice before the implementation of labeling changes recommended by the European Med
Autor:
Marie Linder, Christine L. Bui, Albert Roso-Llorach, Alejandro Arana, Oliver Scholle, Francisca González-Rubio, Beatriz Poblador-Plou, Alexandra Prados-Torres, Maria Giner-Soriano, Jordi Castellsague, Brian Calingaert, Clara Laguna, Susana Perez-Gutthann
Publikováno v:
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Pharmacoepidemiology and Drug Safety
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Pharmacoepidemiology and drug safety, 27(9):953-961
Recercat. Dipósit de la Recerca de Catalunya
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Pharmacoepidemiology and Drug Safety
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Pharmacoepidemiology and drug safety, 27(9):953-961
Recercat. Dipósit de la Recerca de Catalunya
Cilostazol; Intermittent claudication; Peripheral artery disease; Risk minimization Claudicació intermitent; Malaltia vascular perifèrica; Minimització del risc Claudicación intermitente; Enfermedad vascular periférica; Minimización del riesgo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dff33aff5c6cab1a57719054f34d9b0
https://hdl.handle.net/11351/3804
https://hdl.handle.net/11351/3804
Autor:
Mary E Ritchey, Zahidul Islam, Christine L. Bui, Maribel Salas, Nora Tu, Michelle D Hackshaw, Amy Ladner
Publikováno v:
Cancer Treatment and Research Communications, Vol 24, Iss, Pp 100189-(2020)
Background Therapies targeting human epidermal growth factor receptor 2 (HER2) have become a focus for improving treatment outcomes in patients with gastric cancer. This literature review sought to assesses clinical outcomes, including safety, surviv
Autor:
Willem Jan Atsma, Milbhor D’Silva, Ina Anveden Berglind, Susana Perez-Gutthann, Alejandro Arana, Lisa J. McQuay, Nina Sahlertz Kristiansen, Anton Pottegård, Andrea V. Margulis, Christine L. Bui, Kwame Appenteng, Marie Linder, Shahram Bahmanyar, Jesper Hallas
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0204456 (2018)
Margulis, A V, Linder, M, Arana, A, Pottegård, A, Berglind, I A, Bui, C L, Kristiansen, N S, Bahmanyar, S, McQuay, L J, Atsma, W J, Appenteng, K, D'Silva, M, Perez-Gutthann, S & Hallas, J 2018, ' Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom ', PLOS ONE, vol. 13, no. 9, e0204456 . https://doi.org/10.1371/journal.pone.0204456
PLoS ONE
Margulis, A V, Linder, M, Arana, A, Pottegård, A, Berglind, I A, Bui, C L, Kristiansen, N S, Bahmanyar, S, McQuay, L J, Atsma, W J, Appenteng, K, D'Silva, M, Perez-Gutthann, S & Hallas, J 2018, ' Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom ', PLOS ONE, vol. 13, no. 9, e0204456 . https://doi.org/10.1371/journal.pone.0204456
PLoS ONE
Purpose To describe the use of antimuscarinic drugs to treat overactive bladder (OAB) in Denmark, Sweden, and the United Kingdom (UK). Methods We identified new users of darifenacin, fesoterodine, oxybutynin, solifenacin, tolterodine, and trospium ag
Autor:
Mari-Ann Wallander, Nuria Riera-Guardia, Crystal N. Holick, Jordi Castellsague, Brian Calingaert, Scott C. Quinlan, Susana Perez-Gutthann, Kenneth J. Rothman, Lisa J. McQuay, Catherine W. Saltus, Kiliana Suzart, Peter Wahl, James A. Kaye, Christine L. Bui
Publikováno v:
Pharmacotherapy
Study Objective To estimate the incidence and relative risk of a hospitalization or emergency visit for noninfectious liver injury in users of eight oral antimicrobials—amoxicillin, amoxicillin-clavulanic acid, clarithromycin, cefuroxime, doxycycli